Health - Monday, June 1, 2026

States are racing to implement the new requirements by the start of next year.

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.

Thousands of mysterious containers lie scattered across northern Laos. These “death jars” may have provided a form of communal interment, archaeologists reported.

Here is some of what you may have missed from the world's largest cancer research meeting.

At the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.

A Salk Institute study found that a simple dietary amino acid, methionine, dramatically improved survival in mice facing severe infections and inflammatory conditions. Rather than directly targeting the immune system, methionine boosted kidney filtration, helping the body flush out excess inflammatory molecules that can cause tissue damage, brain dysfunction, wasting, and death.

A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with benefits lasting long after treatment ended.

The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.